Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embolization, Therapeutic | 5 | 2016 | 551 | 0.320 |
Why?
|
| Hepatic Artery | 5 | 2016 | 240 | 0.250 |
Why?
|
| Aneurysm, False | 2 | 2016 | 153 | 0.190 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2021 | 209 | 0.180 |
Why?
|
| Radiosurgery | 2 | 2021 | 1330 | 0.170 |
Why?
|
| Cryosurgery | 1 | 2021 | 167 | 0.170 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 114 | 0.170 |
Why?
|
| Prostatic Neoplasms | 3 | 2021 | 5767 | 0.160 |
Why?
|
| Renal Artery | 1 | 2016 | 79 | 0.140 |
Why?
|
| Prostate | 2 | 2020 | 1088 | 0.140 |
Why?
|
| Chest Tubes | 1 | 2016 | 101 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2021 | 831 | 0.140 |
Why?
|
| Hydrogels | 1 | 2016 | 123 | 0.140 |
Why?
|
| Prostatectomy | 1 | 2021 | 962 | 0.140 |
Why?
|
| Liver Neoplasms | 5 | 2016 | 4557 | 0.140 |
Why?
|
| Pneumothorax | 1 | 2016 | 153 | 0.130 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2015 | 32 | 0.130 |
Why?
|
| Chemoembolization, Therapeutic | 2 | 2006 | 181 | 0.130 |
Why?
|
| Radiography, Interventional | 3 | 2016 | 305 | 0.130 |
Why?
|
| Catheterization | 1 | 2016 | 410 | 0.110 |
Why?
|
| Nephrectomy | 1 | 2016 | 779 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5319 | 0.100 |
Why?
|
| Gastrointestinal Stromal Tumors | 2 | 2016 | 297 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2016 | 5542 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2007 | 71 | 0.070 |
Why?
|
| Thrombin | 1 | 2007 | 99 | 0.070 |
Why?
|
| Angioplasty | 1 | 2007 | 94 | 0.070 |
Why?
|
| Quality of Life | 1 | 2021 | 4532 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 7702 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 852 | 0.070 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2005 | 35 | 0.070 |
Why?
|
| Lung | 1 | 2016 | 3151 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2018 | 1863 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 7551 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2010 | 1996 | 0.060 |
Why?
|
| Carcinoid Tumor | 1 | 2005 | 280 | 0.060 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2007 | 690 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 3022 | 0.050 |
Why?
|
| Aged | 9 | 2021 | 70117 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2021 | 32848 | 0.050 |
Why?
|
| Stents | 1 | 2007 | 1096 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 705 | 0.050 |
Why?
|
| Middle Aged | 10 | 2021 | 86204 | 0.050 |
Why?
|
| Male | 11 | 2021 | 123000 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 11538 | 0.040 |
Why?
|
| Lymph Node Excision | 2 | 2021 | 1959 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2016 | 1363 | 0.040 |
Why?
|
| Osteosarcoma | 1 | 2004 | 929 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 10035 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2020 | 37905 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 12873 | 0.030 |
Why?
|
| Humans | 14 | 2021 | 261506 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 14889 | 0.030 |
Why?
|
| Image-Guided Biopsy | 1 | 2018 | 327 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 83 | 0.030 |
Why?
|
| Female | 10 | 2021 | 141928 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 945 | 0.030 |
Why?
|
| Volvocida | 1 | 1993 | 1 | 0.030 |
Why?
|
| Chlorophyta | 1 | 1993 | 10 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 1335 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 750 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 13658 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 1204 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2004 | 2576 | 0.030 |
Why?
|
| Adult | 7 | 2016 | 77950 | 0.030 |
Why?
|
| Disease-Free Survival | 3 | 2010 | 10001 | 0.030 |
Why?
|
| Germ Cells | 1 | 1993 | 335 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 4892 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2010 | 171 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 6311 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 3443 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 4314 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 6009 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 29902 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1472 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2007 | 76 | 0.020 |
Why?
|
| Kidney | 1 | 2016 | 2146 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 12926 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2010 | 1290 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2007 | 164 | 0.020 |
Why?
|
| Angiography | 1 | 2007 | 360 | 0.020 |
Why?
|
| Leg Bones | 1 | 2004 | 11 | 0.020 |
Why?
|
| Radius | 1 | 2004 | 42 | 0.020 |
Why?
|
| Humerus | 1 | 2004 | 53 | 0.020 |
Why?
|
| Survival Rate | 2 | 2010 | 12221 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2015 | 2967 | 0.020 |
Why?
|
| Medical Records | 1 | 2005 | 415 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2004 | 232 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1993 | 4078 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 726 | 0.010 |
Why?
|
| Prognosis | 2 | 2006 | 21713 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2004 | 3005 | 0.010 |
Why?
|
| Cisplatin | 1 | 2004 | 2432 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 3890 | 0.010 |
Why?
|
| Adolescent | 2 | 2007 | 31252 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 8865 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 4744 | 0.010 |
Why?
|
| Child | 2 | 2007 | 29154 | 0.010 |
Why?
|
| Blastomeres | 1 | 1993 | 24 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1993 | 281 | 0.010 |
Why?
|
| Cell Count | 1 | 1993 | 508 | 0.010 |
Why?
|
| Microsurgery | 1 | 1993 | 244 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 5061 | 0.010 |
Why?
|
| Cell Division | 1 | 1993 | 2489 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 17523 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 7789 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 15862 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1993 | 4053 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 14289 | 0.000 |
Why?
|
| Mutation | 1 | 1993 | 15179 | 0.000 |
Why?
|
| Animals | 1 | 1993 | 59536 | 0.000 |
Why?
|